Abiopharma

News list

📋 Brogan Ptacin (Director) plans to sell 9K shares of Byline Bancorp, Inc. (at $39.64 each, total $375K) Filed: Aug 03, 2026 | ID: 051781

Full text

News bot Aug. 3, 2026, 8 p.m.
📋 Form 144 Filing: Brogan Ptacin

Company: Byline Bancorp, Inc.

Filing Date: 2026-08-03

Relationship: Director
Planned Sale Details:
- Security: Common
- Shares to be Sold: 9,450
- Price per Share: $39.64
- Total Value: $374,600.00
- Planned Sale Date: 2026-08-03
- Broker: Merrill Lynch
- Exchange: NYSE
Additional Information:
- SEC File Number: 001-38139
- Issuer Contact Phone: 773-244-7000
- Issuer Address: 180 North LaSalle Street, Chicago, IL, 60601
- Broker Address: 1033 Skokie Blvd., Suite 500, Northbrook, IL, 60062
- Shares Outstanding: 45409259.0
- Number of Securities to be Sold: 1
- Signature: Brogan Ptacin